Laura J Pawlak, RPH, BS PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9265 159th St, Orland Hills, IL 60487 Phone: 708-349-4340 Fax: 708-349-4355 |
Dr. Gina Delis Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9265 159th St, Orland Hills, IL 60487 Phone: 708-349-4340 Fax: 708-349-4355 |
Bilal Salameh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9245 159th St, Orland Hills, IL 60487 Phone: 708-349-4340 |
News Archive
With cholera on the rampage in Haiti and almost 40 other countries, scientists are reporting the development of a key advance that could provide a fast, simple test to detect the toxin that causes the disease. The report appears in ACS' journal Bioconjugate Chemistry. Cholera affects more than 200,000 people annually, mainly in developing countries, and causes about 5,000 deaths. Many involve infants, children, and the elderly.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
Dr. Morris (Mickey) Milner, President and CEO of The Health Technology Exchange (HTX), announced the successful adoption of Sentinelle Medical's new breast imaging system by Kingston General Hospital (KGH), through the HTX's Health Technology Assessment and Implementation Program (HTAIP), a program funded by the Ontario Ministry of Research and Innovation.
A study published in the neurological journal, The Lancet Neurology, has identified that patients with rapid eye movement sleep behavior disorder (RBD) have a dopamine deficiency in the brain and suffer from a form of brain inflammation. They are subjected to increased risks of developing dementia or Parkinson's disease as they grow older.
› Verified 9 days ago